XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

202 hedge funds and large institutions have $2.95B invested in Xenon Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 76 increasing their positions, 62 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
202
Holders Change
-11
Holders Change %
-5.16%
% of All Funds
2.92%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.13%
New
13
Increased
76
Reduced
62
Closed
24
Calls
$4.78M
Puts
$1.13M
Net Calls
+$3.64M
Net Calls Change
-$3.37M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$101M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$38.5M
3
SC
3
Samlyn Capital
New York
$40.2M
4
VPC
4
Vestal Point Capital
New York
$32.5M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$82M

Top Sellers

1
PBA
1
Paradigm Biocapital Advisors
New York
$0
2
Invesco
2
Invesco
Georgia
$8.5M
3
AG
3
Artal Group
Luxembourg
$0
4
LGM
4
Logos Global Management
California
$0
5
BCM
5
Boone Capital Management
Georgia
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
51
Two Sigma Investments
New York
$9.59M +$1.91M +48,450 +25%
Morgan Stanley
52
Morgan Stanley
New York
$9.45M +$46.1K +1,170 +0.5%
Russell Investments Group
53
Russell Investments Group
United Kingdom
$8.8M +$2.39M +60,764 +37%
AG
54
Algert Global
California
$8.65M +$1.43M +36,440 +20%
Invesco
55
Invesco
Georgia
$8.5M -$25.6M -650,963 -75%
Assenagon Asset Management
56
Assenagon Asset Management
Luxembourg
$8.36M +$5.46M +138,685 +188%
ABG
57
Ally Bridge Group
New York
$8.34M +$1.67M +42,422 +25%
Millennium Management
58
Millennium Management
New York
$8.23M +$1.32M +33,442 +19%
D.E. Shaw & Co
59
D.E. Shaw & Co
New York
$8.07M +$1.7M +43,170 +27%
GIM
60
Granahan Investment Management
Massachusetts
$7.91M -$996K -25,289 -11%
PHP
61
Parkman Healthcare Partners
Connecticut
$7.55M -$694K -17,632 -8%
DnB Asset Management
62
DnB Asset Management
Norway
$7.5M +$586K +14,890 +8%
Axa
63
Axa
France
$7.41M +$2.05K +52 +0%
PHS
64
PFM Health Sciences
California
$7.08M +$1.15M +29,324 +19%
Lord, Abbett & Co
65
Lord, Abbett & Co
New Jersey
$6.85M -$632K -16,048 -8%
Schroder Investment Management Group
66
Schroder Investment Management Group
United Kingdom
$6.83M +$3.29M +85,174 +93%
MB
67
MPM BioImpact
Massachusetts
$6.53M +$6.53M +165,800 New
Ensign Peak Advisors
68
Ensign Peak Advisors
Utah
$6.42M – – –
UBS AM
69
UBS AM
Illinois
$6.4M +$8.54K +217 +0.1%
BM
70
Bridger Management
New York
$5.78M – – –
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$5.22M -$721K -18,319 -12%
Bank of America
72
Bank of America
North Carolina
$5.02M -$586K -14,876 -10%
ACM
73
Atika Capital Management
New York
$4.96M +$78.7K +2,000 +2%
Swiss National Bank
74
Swiss National Bank
Switzerland
$4.93M -$31.5K -800 -0.6%
IC
75
Ikarian Capital
Texas
$4.22M – – –
1 2
3
4 5